To provide clinicians and researchers with blood-based diagnostics that are equivalent to the gold standard and for the first time can be available to all patients and enable breakthrough treatment of neurodegenerative diseases.
The APEX platform
Sensor platform for extracellular vesicles
In order to make this vision a reality, we have developed the proprietary APEX platform that detects protein aggregates via extracellular vesicles that pass through the blood-brain barrier.
A Novel Detector of Neurodegenerative Disease
With a leading and highly motivated team of scientists and researchers, Sunbird Bio has proven the capabilities of the platform through a publication in Nature Communications that demonstrated strong correlation of beta amyloid, associated with Alzheimer’s disease, with the gold standard, Amyloid PET (Positron Emission Tomography). Sunbird Bio is rapidly moving towards introducing the technology to the market.
For more information about the APEX platform